A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

被引：0
|
作者：
Takuro Kainuma
Shogo Kawakami
Hideyasu Tsumura
Takefumi Satoh
Ken-ichi Tabata
Masatsugu Iwamura
Kazushige Hayakawa
Hiromichi Ishiyama
机构：
[1] Kitasato University School of Medicine,Department of Radiation Oncology
[2] Kitasato University School of Medicine,Department of Urology
来源：
Radiation Oncology | / 14卷
关键词：
Prostate cancer; Stereotactic body radiotherapy; Dose-escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
    Kainuma, Takuro
    Kawakami, Shogo
    Tsumura, Hideyasu
    Satoh, Takefumi
    Tabata, Ken-ichi
    Iwamura, Masatsugu
    Hayakawa, Kazushige
    Ishiyama, Hiromichi
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [2] UPDATE OF DUTCH MULTICENTER DOSE-ESCALATION TRIAL OF RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER
    Al-Mamgani, Abrahim
    van Putten, Wim L. J.
    Heemsbergen, Wilma D.
    van Leenders, Geert J. L. H.
    Slot, Annerie
    Dielwart, Michel F. H.
    Incrocci, Luca
    Lebesque, Joos V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04): : 980 - 988
  • [3] Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases
    William Rule
    Robert Timmerman
    Liyue Tong
    Ramzi Abdulrahman
    Jeffrey Meyer
    Thomas Boike
    Roderich E. Schwarz
    Paul Weatherall
    L. Chinsoo Cho
    Annals of Surgical Oncology, 2011, 18 : 1081 - 1087
  • [4] Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
    Francesco Deodato
    Milena Ferro
    Paolo Bonome
    Donato Pezzulla
    Carmela Romano
    Milly Buwenge
    Savino Cilla
    Alessio Giuseppe Morganti
    Gabriella Macchia
    Strahlentherapie und Onkologie, 2024, 200 : 239 - 249
  • [5] Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
    Deodato, Francesco
    Ferro, Milena
    Bonome, Paolo
    Pezzulla, Donato
    Romano, Carmela
    Buwenge, Milly
    Cilla, Savino
    Morganti, Alessio Giuseppe
    Macchia, Gabriella
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (3) : 239 - 249
  • [6] STEREOTACTIC BODY RADIOTHERAPY FOR RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: RESULTS OF A PHASE I DOSE-ESCALATION TRIAL
    Heron, Dwight E.
    Ferris, Robert L.
    Karamouzis, Michalls
    Andrade, Regiane S.
    Deeb, Erin L.
    Burton, Steven
    Gooding, William E.
    Branstetter, Barton F.
    Mountz, James M.
    Johnson, Jonas T.
    Argiris, Athanassios
    Grandis, Jennifer R.
    Lai, Stephen Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05): : 1493 - 1500
  • [7] Stereotactic body radiation therapy for prostate cancer: review of experience of a multicenter phase I/Il dose-escalation study
    Kim, D. W. Nathan
    Straka, Christopher
    Cho, L. Chinsoo
    Timmerman, Robert D.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [8] Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
    Kim, Jun Won
    Seong, Jinsil
    Lee, Ik Jae
    Woo, Joong Yeol
    Han, Kwang-Hyub
    ONCOTARGET, 2016, 7 (26) : 40756 - 40766
  • [9] DOSE ESCALATION AND QUALITY OF LIFE IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPY: LONG-TERM RESULTS OF THE DUTCH RANDOMIZED DOSE-ESCALATION TRIAL (CKTO 96-10 TRIAL)
    Al-Mamgani, Abrahim
    van Putten, Wim L. J.
    van der Wielen, Gerard J.
    Levendag, Peter C.
    Incrocci, Luca
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1004 - 1012
  • [10] The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments
    Mesci, Aruz
    Isfahanian, Naghmeh
    Dayes, Ian
    Lukka, Himu
    Tsakiridis, Theodoros
    CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : E25 - E38
12345